Related Experiment Video
Updated: Sep 26, 2025

Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice
Published on: April 27, 2014
Pharmacologic Management of Interstitial Cystitis/Bladder Pain Syndrome
Christopher J Chermansky1, Marina O Guirguis2
1Chief of Urology UPMC Magee Womens Hospital, 300 Halket Street, Suite 2541, Pittsburgh, PA 15213, USA.
Abstract:
Interstitial cystitis/bladder pain syndrome (IC/BPS) is defined as persistent or chronic discomfort perceived to be related to the urinary bladder accompanied by urinary urgency or frequency. Pharmacotherapies used to treat IC/BPS include oral and intravesical agents. Oral therapies include amitriptyline, hydroxyzine, cyclosporine A, and pentosan polysulfate sodium (PPS), although the recent finding of pigmented maculopathy with chronic PPS is very concerning and must be discussed with patients, many of whom will choose to either come off this medicine or not even start it. Certolizumab pegol is a pharmacologic therapy that is currently in clinical development for treatment of IC/BPS symptoms.
More Related Videos
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Irritable Bowel Syndrome III: Medical and Nursing Management
Urinary Tract Infection IV: Nursing Management
Urinary Tract Calculi III: Medical Management

